Skip to content

Warm Water for Unsedated Colonoscopy

Warm Water Irrigation Versus Standard Air Insufflation for Unsedated Colonoscopy: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00905554
Acronym
WW
Enrollment
230
Registered
2009-05-20
Start date
2009-04-30
Completion date
2010-02-28
Last updated
2011-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Keywords

sedation, warm water

Brief summary

Unsedated colonoscopy is characterized by lower costs, recovery time and incidence of drug-related side effects, although it may be painful for the patient. Based on recent reports, the investigators designed this randomized controlled trial hypothesizing that the use of water irrigation versus air insufflation during the insertion phase of colonoscopy might increase the global tolerability of the examination and the proportion of patients undergoing complete colonoscopy without sedation.

Interventions

warm water irrigation during insertion phase of colonoscopy

air insufflation during the insertion phase of colonoscopy

Sponsors

Valduce Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* adult outpatients willing to undergo colonoscopy without routine initial sedation

Exclusion criteria

* refuse to initiate colonoscopy without routine sedation * inadequate bowel preparation * incapacity to give informed consent

Design outcomes

Primary

MeasureTime frame
Number of Patients Undergoing Complete Unsedated Colonoscopy6-9 months

Secondary

MeasureTime frameDescription
Evaluation of Pain and Tolerability Scores6-9 monthsEntity of pain and tolerability level on a visual analogic scale (ranging from 0 - no pain, optimal tolerability - to 100 mm - worst pain ever, unbearable)

Countries

Italy

Participant flow

Recruitment details

medical clinic since march 2009 until sample size was reached

Pre-assignment details

no patient excluded from the study flow after being allocated in the study or control arm

Participants by arm

ArmCount
Warm Water
warm water irrigation during the insertion phase of colonoscopy
116
Air Insufflation
air insufflation during the insertion phase of colonoscopy
114
Total230

Baseline characteristics

CharacteristicAir InsufflationWarm WaterTotal
Age, Categorical
<=18 years
1 Participants2 Participants3 Participants
Age, Categorical
>=65 years
4 Participants6 Participants10 Participants
Age, Categorical
Between 18 and 65 years
109 Participants108 Participants217 Participants
Age Continuous58.8 years
STANDARD_DEVIATION 13.3
58.4 years
STANDARD_DEVIATION 11.5
58.4 years
STANDARD_DEVIATION 12.1
Region of Enrollment
Italy
114 participants116 participants230 participants
Sex: Female, Male
Female
48 Participants48 Participants96 Participants
Sex: Female, Male
Male
66 Participants68 Participants134 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1160 / 114
serious
Total, serious adverse events
0 / 1160 / 114

Outcome results

Primary

Number of Patients Undergoing Complete Unsedated Colonoscopy

Time frame: 6-9 months

ArmMeasureValue (NUMBER)
Warm WaterNumber of Patients Undergoing Complete Unsedated Colonoscopy101 participants
Air InsufflationNumber of Patients Undergoing Complete Unsedated Colonoscopy89 participants
Secondary

Evaluation of Pain and Tolerability Scores

Entity of pain and tolerability level on a visual analogic scale (ranging from 0 - no pain, optimal tolerability - to 100 mm - worst pain ever, unbearable)

Time frame: 6-9 months

ArmMeasureValue (MEDIAN)
Warm WaterEvaluation of Pain and Tolerability Scores28 Scores on a VAS scale
Air InsufflationEvaluation of Pain and Tolerability Scores39 Scores on a VAS scale

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026